Driver and passenger mutations in cancer
- PMID: 25340638
- DOI: 10.1146/annurev-pathol-012414-040312
Driver and passenger mutations in cancer
Abstract
Next-generation sequencing has allowed identification of millions of somatic mutations and epigenetic changes in cancer cells. A key challenge in interpreting cancer genomes and epigenomes is distinguishing which genetic and epigenetic changes are drivers of cancer development. Frequency-based and function-based approaches have been developed to identify candidate drivers; we discuss the advantages and drawbacks of these methods as well as their latest refinements. We focus particularly on identification of the types of drivers most likely to be missed, such as genes affected by copy number alterations, mutations in noncoding regions, dysregulation of microRNA, epigenetic changes, and mutations in chromatin modifiers.
Keywords: bioinformatics; copy number alterations; epigenome; microRNA; regulatory regions.
Similar articles
-
Epigenetic drivers of tumourigenesis and cancer metastasis.Semin Cancer Biol. 2018 Aug;51:149-159. doi: 10.1016/j.semcancer.2017.08.004. Epub 2017 Aug 12. Semin Cancer Biol. 2018. PMID: 28807546 Review.
-
Epigenomic Consequences of Coding and Noncoding Driver Mutations.Trends Cancer. 2016 Oct;2(10):585-605. doi: 10.1016/j.trecan.2016.09.002. Epub 2016 Sep 30. Trends Cancer. 2016. PMID: 28741489 Review.
-
Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.Brief Bioinform. 2016 Jul;17(4):642-56. doi: 10.1093/bib/bbv068. Epub 2015 Aug 24. Brief Bioinform. 2016. PMID: 26307061 Free PMC article. Review.
-
Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.Brief Bioinform. 2014 Mar;15(2):244-55. doi: 10.1093/bib/bbt042. Epub 2013 Jul 1. Brief Bioinform. 2014. PMID: 23818492 Review.
-
[Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].Ann Pathol. 2016 Jan;36(1):80-93. doi: 10.1016/j.annpat.2015.11.012. Epub 2016 Jan 20. Ann Pathol. 2016. PMID: 26803564 French.
Cited by
-
Identification of cancer driver genes based on hierarchical weak consensus model.Health Inf Sci Syst. 2024 Mar 6;12(1):21. doi: 10.1007/s13755-024-00279-6. eCollection 2024 Dec. Health Inf Sci Syst. 2024. PMID: 38464463
-
Patterns of metastatic spread and tumor burden in unselected cancer patients using PET imaging: Implications for the oligometastatic spectrum theory.Clin Transl Radiat Oncol. 2024 Jan 9;45:100724. doi: 10.1016/j.ctro.2024.100724. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38288311 Free PMC article.
-
Distinguishing between driver and passenger mechanisms of aging.Nat Genet. 2024 Feb;56(2):204-211. doi: 10.1038/s41588-023-01627-0. Epub 2024 Jan 19. Nat Genet. 2024. PMID: 38242993 Review.
-
The successive emergence of ERVL-MaLRs in primates.Virus Evol. 2023 Dec 4;9(2):vead072. doi: 10.1093/ve/vead072. eCollection 2023. Virus Evol. 2023. PMID: 38131004 Free PMC article.
-
The ErbB Signaling Network and Its Potential Role in Endometrial Cancer.Epigenomes. 2023 Oct 1;7(4):24. doi: 10.3390/epigenomes7040024. Epigenomes. 2023. PMID: 37873809 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
